Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Smilnak

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Medical Case Reports|January 18, 2022
Calciphylaxis of the penis and distal digits: a case reportGordon Smilnak, Michael Jiang, Bijal Jain
Journal of Alzheimer'S Disease : JAD|May 24, 2020
Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic DiagnosisEric J Schwaber, Atalie C Thompson, Gordon Smilnak, et al.
British Journal of Haematology|February 10, 2022
Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphomaIshan Roy, Gordon Smilnak, Madelyn Burkart, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal MeningoencephalitisLaura L Kovanda, Charles Giamberardino, Laura McEntee, et al.
Neuro-Oncology Advances|July 10, 2020
Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastasesTiffany Ejikeme, George C de Castro, Katelyn Ripple, et al.
Blood Advances|February 3, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphomaGeoffrey Shouse, Andy Kaempf, Max J Gordon, et al.
Research Square|November 19, 2025
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective StudyMatthew Hamby, Brian Egleston, Zachary Frosch, et al.
Blood Cancer Journal|March 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective studyMatthew Hamby, Brian L Egleston, Zachary A K Frosch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Medical Case Reports|January 18, 2022
Calciphylaxis of the penis and distal digits: a case reportGordon Smilnak, Michael Jiang, Bijal Jain
Journal of Alzheimer'S Disease : JAD|May 24, 2020
Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic DiagnosisEric J Schwaber, Atalie C Thompson, Gordon Smilnak, et al.
British Journal of Haematology|February 10, 2022
Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphomaIshan Roy, Gordon Smilnak, Madelyn Burkart, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal MeningoencephalitisLaura L Kovanda, Charles Giamberardino, Laura McEntee, et al.
Neuro-Oncology Advances|July 10, 2020
Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastasesTiffany Ejikeme, George C de Castro, Katelyn Ripple, et al.
Blood Advances|February 3, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphomaGeoffrey Shouse, Andy Kaempf, Max J Gordon, et al.
Research Square|November 19, 2025
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective StudyMatthew Hamby, Brian Egleston, Zachary Frosch, et al.
Blood Cancer Journal|March 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective studyMatthew Hamby, Brian L Egleston, Zachary A K Frosch, et al.
Pageof 1